Abstract
Asthma and chronic obstructive pulmonary disease (COPD) are distinct respiratory diseases with unmet medical needs affecting hundreds of millions of patients worldwide. While asthma and COPD do share a number of common features as they are chronic inflammatory conditions of the lung, they are clearly different diseases with unique characteristics and causes. However, treatment of both these diseases remains primarily the same. There is clearly a need for different drug classes to be developed for the treatment of these conditions. The use of animal models in investigating potential new drugs for asthma has tried to replicate both the early and late asthmatic response to allergen challenge, bronchial hyperresponsiveness, and airway remodelling. Historically, the guinea pig was the species of choice with its many advantages. However, more recently mice have been more widely used in preclinical research although they lack many features of the human condition. The primary characteristic of COPD that is replicated in animal models is non-allergic inflammation. The main challenge with this is that COPD often develops over a significant period of time which is difficult to accurately replicate in an animal model. Once again, different species have been used to best investigate the various aspects of this inflammation. In addition, cough is also an important feature of chronic lung conditions for which no treatment has been approved. Establishing improved animal models that exhibit a hypertussive response would be essential in the development of antitussive drugs. Overall, there is a clear need for the development of improved animal models to aid in the discovery and development of new treatments in both asthma and COPD.
Similar content being viewed by others
References and Further Reading
Adcock JJ, Douglas GJ, Garabette M, Gascoigne M, Beatch G, Walker M, Page CP (2003) RSD931, a novel anti-tussive agent acting on airway sensory nerves. Br J Pharmacol 138(3):407–416
Adner M, Canning BJ, Meurs H, Ford W, Ramos Ramirez P, van den Berg MPM, Birrell MA, Stoffels E, Lundblad LKA, Nilsson GP, Olsson HK, Belvisi MG, Dahlen SE (2020) Back to the future: re-establishing guinea pig in vivo asthma models. Clin Sci (Lond) 134(11):1219–1242
Anderson SD (2010) Indirect challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 138(2 Suppl):25S–30S
Anderson SD, Brannan JD (2010) Bronchial provocation testing and collection of sputum with inhaled mannitol. Clin Exp Allergy 40(2):193–196
Aun MV, Bonamichi-Santos R, Arantes-Costa FM, Kalil J, Giavina-Bianchi P (2017) Animal models of asthma: utility and limitations. J Asthma Allergy 10:293–301
Barnes PJ (1998) Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 94(6):557–572
Barnes PJ (2007a) Prevention of death in COPD. N Engl J Med 356(21):2211, author reply 2213–4
Barnes PJ (2007b) Scientific rationale for using a single inhaler for asthma control. Eur Respir J 29(3):587–595
Barnes PJ (2014) Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med 35(1):71–86
Belvisi MG, Birrell MA, Wortley MA, Maher SA, Satia I, Badri H, Holt K, Round P, McGarvey L, Ford J, Smith JA (2017) XEN-D0501, a novel transient receptor potential vanilloid 1 antagonist, does not reduce cough in patients with refractory cough. Am J Respir Crit Care Med 196(10):1255–1263
Berry B, Wright JL (1991) Long-term pulmonary hypertension produced by cigarette smoking is associated with subendocardial fibrosis and inflammation of the right ventricle: a morphometric analysis in the guinea pig model. Exp Pathol 43(3–4):163–172
Birring SS, Wijsenbeek MS, Agrawal S, van den Berg JWK, Stone H, Maher TM, Tutuncu A, Morice AH (2017) A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial. Lancet Respir Med 5(10):806–815
Bonvini SJ, Birrell MA, Smith JA, Belvisi MG (2015) Targeting TRP channels for chronic cough: from bench to bedside. Naunyn Schmiedeberg’s Arch Pharmacol 388(4):401–420
Boura AL, Green AF, Saunders IA (1970) An antitussive test using guinea-pigs. Br J Pharmacol 39(1):225P
Bousquet J, Clark TJ, Hurd S, Khaltaev N, Lenfant C, O'Byrne P, Sheffer A (2007) GINA guidelines on asthma and beyond. Allergy 62(2):102–112
Brown RA, Clarke GW, Ledbetter CL, Hurle MJ, Denyer JC, Simcock DE, Coote JE, Savage TJ, Murdoch RD, Page CP, Spina D, O’Connor BJ (2008) Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects. Eur Respir J 31(2):311–319
Brusasco V, Crimi E, Pellegrino R (1998) Airway hyperresponsiveness in asthma: not just a matter of airway inflammation. Thorax 53(11):992–998
Buday T, Gavliakova S, Mokry J, Medvedova I, Kavalcikova-Bogdanova N, Plevkova J (2016) The Guinea pig sensitized by house dust mite: a model of experimental cough studies. Adv Exp Med Biol 905:87–95
Buels KS, Fryer AD (2012) Muscarinic receptor antagonists: effects on pulmonary function. Handb Exp Pharmacol 208:317–341
Busse WW (2012) What is the best pulmonary diagnostic approach for wheezing patients with normal spirometry? Respir Care 57(1):39–46, discussion 47–9
Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ, M and groups, M. s. (2009) Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 374(9691):685–694
Canning BJ (2003) Modeling asthma and COPD in animals: a pointless exercise? Curr Opin Pharmacol 3(3):244–250
Carrington R, Jordan S, Pitchford SC, Page CP (2018) Use of animal models in IPF research. Pulm Pharmacol Ther 51:73–78
Cazzola M, Rogliani P, Calzetta L, Lauro D, Page C, Matera MG (2017) Targeting mechanisms linking COPD to type 2 diabetes mellitus. Trends Pharmacol Sci 38(10):940–951
Chapman DG, Tully JE, Nolin JD, Janssen-Heininger YM, Irvin CG (2014) Animal models of allergic airways disease: where are we and where to next? J Cell Biochem 115(12):2055–2064
Chung KF (2013) New treatments for severe treatment-resistant asthma: targeting the right patient. Lancet Respir Med 1(8):639–652
Chung HS, Kang M, Cho C, Parvez S, Park CH, Kim D, Oh J, Kim H, Shin M, Hong M, Kim Y, Bae H (2007) Inhibition of nitric oxide and tumor necrosis factor-alpha by moutan cortex in activated mouse peritoneal macrophages. Biol Pharm Bull 30(5):912–916
Churg A, Cosio M, Wright JL (2008) Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am J Physiol Lung Cell Mol Physiol 294(4):L612–L631
Cisneros-Lira J, Gaxiola M, Ramos C, Selman M, Pardo A (2003) Cigarette smoke exposure potentiates bleomycin-induced lung fibrosis in guinea pigs. Am J Physiol Lung Cell Mol Physiol 285(4):L949–L956
Clay E, Patacchini R, Trevisani M, Preti D, Brana MP, Spina D, Page C (2016) Ozone-induced Hypertussive responses in rabbits and guinea pigs. J Pharmacol Exp Ther 357(1):73–83
Cockcroft DW (2010) Direct challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 138(2 Suppl):18S–24S
Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE (1977) Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 7(3):235–243
Dahlen SE (2006) Treatment of asthma with antileukotrienes: first line or last resort therapy? Eur J Pharmacol 533(1–3):40–56
Dal Negro RW, Wedzicha JA, Iversen M, Fontana G, Page C, Cicero AF, Pozzi E, Calverley PMA, RESTORE group, RESTORE study (2017) Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study. Eur Respir J 50(4):1700711
Dalen H (1983) An ultrastructural study of the tracheal epithelium of the guinea-pig with special reference to the ciliary structure. J Anat 136(Pt 1):47–67
Dekhuijzen R, Lavorini F, Usmani OS, van Boven JFM (2018) Addressing the impact and unmet needs of nonadherence in asthma and chronic obstructive pulmonary disease: where do we go from here? J Allergy Clin Immunol Pract 6(3):785–793
Dell SD, Bola SS, Foty RG, Marshall LC, Nelligan KA, Coates AL (2015) Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers. Ann Am Thorac Soc 12(3):357–363
Demoly P, Paggiaro P, Plaza V, Bolge SC, Kannan H, Sohier B, Adamek L (2009) Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK. Eur Respir Rev 18(112):105–112
Dicpinigaitis PV, Morice AH, Birring SS, McGarvey L, Smith JA, Canning BJ, Page CP (2014) Antitussive drugs – past, present, and future. Pharmacol Rev 66(2):468–512
Drake MG, Scott GD, Blum ED, Lebold KM, Nie Z, Lee JJ, Fryer AD, Costello RW, Jacoby DB (2018) Eosinophils increase airway sensory nerve density in mice and in human asthma. Sci Transl Med 10(457):eaar8477
Dunnill MS (1971) The pathology of asthma. Ciba Found Study Group 38:35–46
el-Hashim A, D’Agostino B, Matera MG, Page C (1996) Characterization of adenosine receptors involved in adenosine-induced bronchoconstriction in allergic rabbits. Br J Pharmacol 119(6):1262–1268
Fernandez-Blanco JA, Aguilera M, Domenech A, Tarrason G, Prats N, Miralpeix M, De Alba J (2015) Enhanced cough reflex in a model of bleomycin-induced lung fibrosis in guinea pigs. Clin Sci (Lond) 129(12):1001–1010
Finney L, Berry M, Singanayagam A, Elkin SL, Johnston SL, Mallia P (2014) Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary disease. Lancet Respir Med 2(11):919–932
Fowdar K, Chen H, He Z, Zhang J, Zhong X, Zhang J, Li M, Bai J (2017) The effect of N-acetylcysteine on exacerbations of chronic obstructive pulmonary disease: a meta-analysis and systematic review. Heart Lung 46(2):120–128
Fowler SJ, Dempsey OJ, Sims EJ, Lipworth BJ (2000) Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to asthma severity and beta(2)-receptor genotype. Am J Respir Crit Care Med 162(4 Pt 1):1318–1322
Franciosi LG, Diamant Z, Banner KH, Zuiker R, Morelli N, Kamerling IM, de Kam ML, Burggraaf J, Cohen AF, Cazzola M, Calzetta L, Singh D, Spina D, Walker MJ, Page CP (2013) Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials. Lancet Respir Med 1(9):714–727
Galli SJ, Tsai M (2012) IgE and mast cells in allergic disease. Nat Med 18(5):693–704
Ghorani V, Boskabady MH, Khazdair MR, Kianmeher M (2017) Experimental animal models for COPD: a methodological review. Tob Induc Dis 15:25
GINA (2020) Global strategy for asthma management and prevention. Available at: https://ginasthma.org/reports/
Global Burden of Disease Study (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390(10100):1211–1259
GOLD (2020) 2020 global strategy for prevention, diagnosis and management of COPD. Available at: https://goldcopd.org/gold-reports/
Green AF, Ward NB (1955) The action of analgesics and nalorphine on the cough reflex. Br J Pharmacol Chemother 10(4):418–423
Grootendorst DC, Rabe KF (2004) Mechanisms of bronchial hyperreactivity in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 1(2):77–87
Hammad H, Lambrecht BN (2015) Barrier epithelial cells and the control of type 2 immunity. Immunity 43(1):29–40
Han B, Poppinga WJ, Zuo H, Zuidhof AB, Bos IS, Smit M, Vogelaar P, Krenning G, Henning RH, Maarsingh H, Halayko AJ, van Vliet B, Stienstra S, Graaf AC, Meurs H, Schmidt M (2016) The novel compound Sul-121 inhibits airway inflammation and hyperresponsiveness in experimental models of chronic obstructive pulmonary disease. Sci Rep 6:26928
Hogg JC, Timens W (2009) The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 4:435–459
Holmes AM, Solari R, Holgate ST (2011) Animal models of asthma: value, limitations and opportunities for alternative approaches. Drug Discov Today 16(15–16):659–670
Horton MR, Santopietro V, Mathew L, Horton KM, Polito AJ, Liu MC, Danoff SK, Lechtzin N (2012) Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial. Ann Intern Med 157(6):398–406
Jack D (1991) The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta-adrenoceptor agonists. Br J Clin Pharmacol 31(5):501–514
Jones TR, Labelle M, Belley M, Champion E, Charette L, Evans J, Ford-Hutchinson AW, Gauthier JY, Lord A, Masson P et al (1995) Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol 73(2):191–201
Karlsson JA, Hansson L, Wollmer P, Dahlback M (1991) Regional sensitivity of the respiratory tract to stimuli causing cough and reflex bronchoconstriction. Respir Med 85(Suppl A):47–50
Keir S, Boswell-Smith V, Spina D, Page C (2006) Mechanism of adenosine-induced airways obstruction in allergic guinea pigs. Br J Pharmacol 147(7):720–728
Keir SD, Spina D, Douglas G, Herd C, Page CP (2011) Airway responsiveness in an allergic rabbit model. J Pharmacol Toxicol Methods 64(2):187–195
Keir SD, Spina D, Page CP (2015) Bradykinin and capsaicin induced airways obstruction in the guinea pig are platelet dependent. Pulm Pharmacol Ther 33:25–31
Lambrecht BN, Hammad H (2012) The airway epithelium in asthma. Nat Med 18(5):684–692
Lexmond AJ, Keir S, Terakosolphan W, Page CP, Forbes B (2018) A novel method for studying airway hyperresponsiveness in allergic guinea pigs in vivo using the PreciseInhale system for delivery of dry powder aerosols. Drug Deliv Transl Res 8(3):760–769
Li X, Wilson JW (1997) Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 156(1):229–233
Li X, Cao X, Guo M, Xie M, Liu X (2020) Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017. BMJ 368:m234
Lieutier-Colas F, Purohit A, Meyer P, Fabries JF, Kopferschmitt MC, Dessanges JF, Pauli G, de Blay F (2003) Bronchial challenge tests in patients with asthma sensitized to cats: the importance of large particles in the immediate response. Am J Respir Crit Care Med 167(8):1077–1082
Lloyd CM, Gonzalo JA, Coyle AJ, Gutierrez-Ramos JC (2001) Mouse models of allergic airway disease. Adv Immunol 77:263–295
Lundgren R, Soderberg M, Horstedt P, Stenling R (1988) Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J 1(10):883–889
Lungarella G, Barni-Comparini I, Fonzi L (1984) Pulmonary changes induced in rabbits by long-term exposure to n-hexane. Arch Toxicol 55(4):224–228
Manzini S (1992) Bronchodilatation by tachykinins and capsaicin in the mouse main bronchus. Br J Pharmacol 105(4):968–972
McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, Wright AC, Gefter WB, Litzky L, Coxson HO, Pare PD, Sin DD, Pierce RA, Woods JC, McWilliams AM, Mayo JR, Lam SC, Cooper JD, Hogg JC (2011) Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 365(17):1567–1575
Menzella F, Galeone C, Bertolini F, Castagnetti C, Facciolongo N (2017) Innovative treatments for severe refractory asthma: how to choose the right option for the right patient? J Asthma Allergy 10:237–247
Meshi B, Vitalis TZ, Ionescu D, Elliott WM, Liu C, Wang XD, Hayashi S, Hogg JC (2002) Emphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response. Am J Respir Cell Mol Biol 26(1):52–57
Miller I, Rogel-Gaillard C, Spina D, Fontanesi L, de Almeida AM (2014) The rabbit as an experimental and production animal: from genomics to proteomics. Curr Protein Pept Sci 15(2):134–145
Minshall EM, Riccio MM, Herd CM, Douglas GJ, Seeds EA, McKenniff MG, Sasaki M, Spina D, Page CP (1993) A novel animal model for investigating persistent airway hyperresponsiveness. J Pharmacol Toxicol Methods 30(4):177–188
Muccitelli RM, Tucker SS, Hay DW, Torphy TJ, Wasserman MA (1987) Is the guinea pig trachea a good in vitro model of human large and central airways? Comparison on leukotriene-, methacholine-, histamine- and antigen-induced contractions. J Pharmacol Exp Ther 243(2):467–473
Nishi Y, Boswell V, Ansari T, Piprawala F, Satchi S, Page CP (2003) Elastase-induced changes in lung function: relationship to morphometry and effect of drugs. Pulm Pharmacol Ther 16(4):221–229
O’Byrne PM, Inman MD (2003) Airway hyperresponsiveness. Chest 123(3 Suppl):411S–416S
Page C, Black J (1994) Airways and vascular remodelling in asthma and cardiovascular disease: implications for therapeutic intervention: based on the Scientific Program, Silverado, Napa Valley, California, May 12th–14th, 1993. Academic, London
Page C, O’Shaughnessy B, Barnes P (2017) Pathogenesis of COPD and asthma. Handb Exp Pharmacol 237:1–21
Palmqvist M, Cui ZH, Sjostrand M, Linden A, Lotvall J (2001) Reduced late asthmatic response by repeated low-dose allergen exposure. Eur Respir J 17(5):872–880
Pare PD, McParland BE, Seow CY (2007) Structural basis for exaggerated airway narrowing. Can J Physiol Pharmacol 85(7):653–658
Patel NR, Cunoosamy DM, Fageras M, Taib Z, Asimus S, Hegelund-Myrback T, Lundin S, Pardali K, Kurian N, Ersdal E, Kristensson C, Korsback K, Palmer R, Brown MN, Greenaway S, Siew L, Clarke GW, Rennard SI, Make BJ, Wise RA, Jansson P (2018) The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial. Int J Chron Obstruct Pulmon Dis 13:1009–1019
Pauwels RA, Lofdahl CG, Laitinen LA, Schouten JP, Postma DS, Pride NB, Ohlsson SV (1999) Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 340(25):1948–1953
Persson CG, Erjefalt JS, Korsgren M, Sundler F (1997) The mouse trap. Trends Pharmacol Sci 18(12):465–467
Phillipps GH (1990) Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med 84(Suppl A):19–23
Piper PJ (1985) Leukotrienes: potent mediators of airway constriction. Int Arch Allergy Appl Immunol 76(Suppl 1):43–48
Pitchford SC, Riffo-Vasquez Y, Sousa A, Momi S, Gresele P, Spina D, Page CP (2004) Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. Blood 103(2):639–647
Platts-Mills TA, Wheatley LM (1996) The role of allergy and atopy in asthma. Curr Opin Pulm Med 2(1):29–34
Poblete MT, Garces G, Figueroa CD, Bhoola KD (1993) Localization of immunoreactive tissue kallikrein in the seromucous glands of the human and guinea-pig respiratory tree. Histochem J 25(11):834–839
Postma DS, Rabe KF (2015) The asthma-COPD overlap syndrome. N Engl J Med 373(13):1241–1249
Prior H, Baldrick P, Beken S, Booler H, Bower N, Brooker P, Brown P, Burlinson B, Burns-Naas LA, Casey W, Chapman M, Clarke D, de Haan L, Doehr O, Downes N, Flaherty M, Gellatly N, Moesgaard SG, Harris J, Holbrook M, Hui J, Jones D, Jones K, Kedar H, Mahl A, Manninen A, McGuire A, Mortimer-Cassen E, Peraza M, Pugsley MK, Richard J, Roberts R, Roosen W, Rothfuss A, Schoenmakers A, Sewell F, Weaver R, Weir L, Wolfreys A, Kimber I (2020) Opportunities for use of one species for longer-term toxicology testing during drug development: a cross-industry evaluation. Regul Toxicol Pharmacol 113:104624
Reed CE (1986) New therapeutic approaches in asthma. J Allergy Clin Immunol 77(4):537–543
Ressmeyer AR, Larsson AK, Vollmer E, Dahlen SE, Uhlig S, Martin C (2006) Characterisation of guinea pig precision-cut lung slices: comparison with human tissues. Eur Respir J 28(3):603–611
Reynolds SM, Docherty R, Robbins J, Spina D, Page CP (2008) Adenosine induces a cholinergic tracheal reflex contraction in guinea pigs in vivo via an adenosine A1 receptor-dependent mechanism. J Appl Physiol (1985) 105(1):187–196
Rogliani P, Matera MG, Page C, Puxeddu E, Cazzola M, Calzetta L (2019) Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine. Respir Res 20(1):104
Sadarani BN, Majumdar AS (2015) Resveratrol potentiates the effect of dexamethasone in rat model of acute lung inflammation. Int Immunopharmacol 28(1):773–779
Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA (2001) Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164(9):1618–1623
Short PM, Lipworth SI, Elder DH, Schembri S, Lipworth BJ (2011) Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ 342:d2549
Singh D, Beeh KM, Colgan B, Kornmann O, Leaker B, Watz H, Lucci G, Geraci S, Emirova A, Govoni M, Nandeuil MA (2019) Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD. Respir Res 20(1):180
Smith JA, Badri H (2019) Cough: new pharmacology. J Allergy Clin Immunol Pract 7(6):1731–1738
Sonnex K, Alleemudder H, Knaggs R (2020) Impact of smoking status on the efficacy of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review. BMJ Open 10(4):e037509
Spina D, Page CP (2002) Asthma – a need for a rethink? Trends Pharmacol Sci 23(7):311–315
Sterk PJ, Bel EH (1989) Bronchial hyperresponsiveness: the need for a distinction between hypersensitivity and excessive airway narrowing. Eur Respir J 2(3):267–274
Tepper RS, Wise RS, Covar R, Irvin CG, Kercsmar CM, Kraft M, Liu MC, O’Connor GT, Peters SP, Sorkness R, Togias A (2012) Asthma outcomes: pulmonary physiology. J Allergy Clin Immunol 129(3 Suppl):S65–S87
Touvay C, Pfister A, Vilain B, Carre C, Page CP, Lellouch-Tubiana A, Pignol B, Mencia-Huerta JM, Braquet P (1991) Effect of long-term infusion of platelet-activating factor on pulmonary responsiveness and morphology in the guinea-pig. Pulm Pharmacol 4(1):43–51
Traver GA, Cline MG, Burrows B (1979) Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. Am Rev Respir Dis 119(6):895–902
Van Den Berge M, Meijer RJ, Kerstjens HA, de Reus DM, Koeter GH, Kauffman HF, Postma DS (2001) PC(20) adenosine 5′-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine. Am J Respir Crit Care Med 163(7):1546–1550
Van Schoor J, Pauwels R, Joos G (2005) Indirect bronchial hyper-responsiveness: the coming of age of a specific group of bronchial challenges. Clin Exp Allergy 35(3):250–261
Venkatasamy R, McKenzie A, Page CP, Walker MJ, Spina D (2010) Use of within-group designs to test anti-tussive drugs in conscious guinea-pigs. J Pharmacol Toxicol Methods 61(2):157–162
Vestbo J, TORCH Study Group (2004) The TORCH (towards a revolution in COPD health) survival study protocol. Eur Respir J 24(2):206–210
Ward AJ, McKenniff MG, Evans JM, Page CP, Costello JF (1994) Bronchial responsiveness is not always increased after allergen challenge. Respir Med 88(6):445–451
Wedzicha JA, Seemungal TA (2007) COPD exacerbations: defining their cause and prevention. Lancet 370(9589):786–796
Wenzel SE (2012) Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 18(5):716–725
Widdicombe JG (1980) Mechanism of cough and its regulation. Eur J Respir Dis Suppl 110:11–20
Winter CA, Flataker L (1954) Antitussive compounds: testing methods and results. J Pharmacol Exp Ther 112(1):99–108
Woisin FE, Herd CM, Douglas GJ, Raynor K, Spina D, Mitchell HW, Page CP (2001) Relationship of airway responsiveness with airway morphometry in normal and immunized rabbits. Pulm Pharmacol Ther 14(2):75–83
Wright JL, Churg A (1990) Cigarette smoke causes physiologic and morphologic changes of emphysema in the guinea pig. Am Rev Respir Dis 142(6 Pt 1):1422–1428
Wright JL, Churg A (1991) Effect of long-term cigarette smoke exposure on pulmonary vascular structure and function in the guinea pig. Exp Lung Res 17(6):997–1009
Wright JL, Sun JP (1994) Effect of smoking cessation on pulmonary and cardiovascular function and structure: analysis of guinea pig model. J Appl Physiol (1985) 76(5):2163–2168
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Keir-Rudman, S.D., Riffo-Vasquez, Y., Robaina Cabrera, C.L., Page, C.P. (2020). Experimental Methods for Evaluating Pharmacodynamic Effects of Drugs for the Pulmonary System. In: Hock, F.J., Gralinski, M.R. (eds) Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-319-56637-5_73-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-56637-5_73-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56637-5
Online ISBN: 978-3-319-56637-5
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences